Safety and Efficacy Study of the NeuGuide Device
This trial is active, not recruiting.
|Condition||pelvic organ prolapse|
|Sponsor||Pop Medical Solutions|
|Start date||November 2014|
|End date||April 2016|
|Trial size||15 participants|
|Trial identifier||NCT02190825, CD0040|
This study aims to investigate the safety, efficacy, peri and postoperative complications, and patient satisfaction of sacro-spinous ligament fixation (SSLF) for the management of pelvic organ prolapse (POP).
Prolapse staging for all subjects in this study will be performed according to the POP-Q staging system.
Ultrasound examinations for all subjects in this study are subjected to the surgeon need and will be performed if required by qualified personnel
|Endpoint classification||safety/efficacy study|
|Intervention model||single group assignment|
Stage of pelvic floor prolapse as defined by POP-Q score
time frame: 6 months
Complications (SAE, AE)
time frame: Up to 6 months
Female participants from 18 years up to 80 years old.
- Women ages 18-80 years old
- POP-Q stage III prolapse or higher
- Scheduled to undergo a POP Surgery and has agreed to undergo it using the NeuGuideTM device
- Patient is willing to return for follow-up evaluation and fill questionnaires as indicated on study protocol
- No exclusion criteria fulfilled
- Diagnosis of reproductive tract anomalies
- Prior pelvic radiation therapy or any malignancy
- Inability to complete written questionnaires.
- Women with significant Pelvic Inflammatory Disease (PID) history
- Women with known allergy to Nickel or Nitinol
Call for more information